Search for a command to run...
Shamrock Industrial Company Ltd. shows significant weaknesses compared to its peers in terms of profitability, valuation, and growth metrics. While the sector leader Sun Pharmaceutical Industries Ltd. stands out with robust revenue growth and profitability, Shamrock's lack of revenue and negative P/E ratio indicates financial stress. This analysis highlights Sun Pharma as a strong performer, while Shamrock is financially risky and underperforming.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Shamrock Industrial Company Ltd. | ₹16.77 | ₹9.10Cr | -150.40 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |